¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦18ȸ µ¿°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2022-01-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦18ȸ µ¿°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2022-01-08
±³À°ÀÏÀÚ : 2022-01-08
±³À°Àå¼Ò : ¿Â¶óÀÎ-¿ÀÇÁ¶óÀκ´Çà(±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º ±×·£µåº¼·ë ¿Ü 3°³·ë)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦18ȸ µ¿°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : À̵µÀÌ
¿¬¶ôó : 02-582-8222  
À̸ÞÀÏ : doi@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í -´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¤È¸¿ø/ȸ¿ø: ¹«·á-Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ,ÀüÀÓÀÇ,Àü°øÀÇ: 20,000¿ø-°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç: 10,000¿ø-»ê¾÷ü,±âŸ: 50,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-08 Presentation Arena 09:00~09:12 Bailout Use of RDR in a Failed Case  ÀÌÇÊÇü(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 01-08 Presentation Arena 09:12~09:24 Collateral Perforation; Cause and Management  ÃÖÀÍÁØ(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 01-08 Presentation Arena 09:24~09:36 Use LIMA (or SVG) for CTO-PCI in a Post-CABG Patient  Àü±¹Áø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 01-08 Presentation Arena 09:36~09:48 Antegrade Planning for Stumpless CTO  ±èµ¿ºó(Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 01-08 Presentation Arena 09:48~10:00 Gear Entrapment and Loss; Prevention and Management  À¯Ã¶¿õ(°í·ÁÀÇ´ë) 
È޽Ġ01-08  10:00~10:10 Break Time  () 
±³À°½Ã°£ 01-08 Seminar Room 10:10~10:25 Diagnostic Value of Wearable Continuous ECG Monitoring Patch, ATP-C120, For New-onset Atrial Fibrillation in High Risk Patients  ±ÇÁÖ¼º(ºÐ´ç¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-08 Seminar Room 10:25~10:40 Platelet Reactivity and Prognostic Implication After Drug-Eluting Stent Implantation in Patients with Complex PCI: Results From the PTRG-DES Consortium  ±èÇö(µ¿¾Æ´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-08 Seminar Room 10:40~10:55 Differential Prognostic Impact of Fractional Flow Reserve Measured after Coronary Stent Implantation by Left Ventricular Function  ¹Ú¼ö°Ç(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 01-08 Seminar Room 10:55~11:10 Practical Experience with Ticagrelor: Insights from a Real-world ¡°BK Registry¡±  ÀÌÇнÂ(¼­¿ï´ëÇб³º´¿ø) 
È޽Ġ01-08  11:10~11:20 Break Time  () 
±³À°½Ã°£ 01-08 Presentation Arena 11:20~11:35 Successful Multidisciplinary Management of Massive PTE and Paradoxical Embolism  ±è»óÈÆ(Â÷ÀÇ´ë ºÐ´çÂ÷º´¿ø) 
±³À°½Ã°£ 01-08 Presentation Arena 11:35~11:50 Recurrent Type A Aortic Dissection in a High Surgical Risk Patient Successfully Managed by Fenestrated Stentgraft  ³ª½Â¿î(°í·ÁÀÇ´ë ±¸·Îº´¿ø) 
±³À°½Ã°£ 01-08 Presentation Arena 11:50~12:05 A Case of Hemolysis and Petechiae after Ratational Atherectomy of Heavily Calcified CFA to SFA CTO  ¹Ú¼ºÈÆ(ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-08 Presentation Arena 12:05~12:20 The Long-Term Fate of Iliac Branch Device  À念¿ì(°¡ÃµÀÇ´ë ±æº´¿ø) 
È޽Ġ01-08  12:20~12:30 Break Time  () 
±³À°½Ã°£ 01-08 Symposium Arena 12:30~12:50 Is Combination Therapy Recommended for All High Risk Patients: When and Why Combination Therapy Is Needed?  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-08 Symposium Arena 12:50~13:10 The Benefit of High Intensity Atorvastatin/Ezetimine Combination Therapy in Coronary Risk Patients with Hypercholesterolemia  °­¹Î±Ô(°æ»óÀÇ´ë) 
Åä·Ð 01-08 Symposium Arena 13:10~13:30 Discussion  () 
±âŸ 01-08 Main Arena 13:30~14:00 KSIC General Meeting  () 
±³À°½Ã°£ 01-08 Presentation Arena 14:00~14:15 Stent Dislodgement Force of Drug-Eluting Coronary Stents: A Bench Test  ¾çÇü¸ð(¾ÆÁÖ´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-08 Presentation Arena 14:15~14:30 Evaluation of Bleeding Events in Patients with Atrial Fibrillation Receiving Concomitant Oral Anticoagulant-Antiplatelets  ÃÖ¼±¿µ(µ¿¾Æ´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-08 Presentation Arena 14:30~14:45 Prognosis and Medical Cost of Measuring Fractional Flow Reserve in Percutaneous Coronary Intervention  È«´ÙÀ§(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 01-08 Presentation Arena 14:45~15:00 Durable Polymer and Biodegradable Polymer Drug-Eluting Stents after Complex Coronary Intervention in Acute Coronary Syndrome: A Post Hoc Analysis from the HOST-REDUCE-POLYTECH-ACS Trial  È²µµ¿¬(¼­¿ï´ëÇб³º´¿ø) 
È޽Ġ01-08  15:00~15:10 Break Time  () 
±³À°½Ã°£ 01-08 Symposium Arena 15:10~15:25 How to Overcome This Recurrent ISR  ÀÌÀåÈÆ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 01-08 Symposium Arena 15:25~15:40 How to Overcome This ISR CTO  ÀåÀç½Ä(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 01-08 Symposium Arena 15:40~15:55 How to Overcome This Bifurcation ISR  ÃÖ±âÈ«(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 01-08 Symposium Arena 15:55~16:10 How to Select DCB Treatment or Stent Overlap in These ISR Lesions  ÃßÀºÈ£(°¡Å縯ÀÇ´ë) 
È޽Ġ01-08  16:10~16:20 Break Time  () 
±³À°½Ã°£ 01-08 Symposium Arena 16:20~16:30 Coronary CT Angiogram: Who Needs It? What  ½Å»óÈÆ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 01-08 Symposium Arena 16:30~16:40 Coronary Angiogram: That Will Do!  °íÁø½Å(°æ»óÀÇ´ë) 
±³À°½Ã°£ 01-08 Symposium Arena 16:40~16:50 Intravascular Imaging Guidance PCI: When and How?   ÀÌÁø¹è(´ë±¸Ä«Å縯ÀÇ´ë) 
±³À°½Ã°£ 01-08 Symposium Arena 16:50~17:00 Vulnerable Plaque: Is It a Crystal Ball?   À±ÇõÁØ(°è¸íÀÇ´ë) 
Åä·Ð 01-08 Symposium Arena 17:00~17:20 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦18ȸ µ¿°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2022-01-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)´ëÇÑ°£ÇÐȸ-¹®¸Æ¾ÐÇ×ÁøÁõ¿¬±¸È¸ 2021³â Á¤±â ½ÉÆ÷Áö¾ö : 2022-01-08
´ÙÀ½±Û 2022 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇÐ ¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¿ò : 2022-01-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 6 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 6 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 4 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 4 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 5 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 4 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 1 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 1 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 1 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 3 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 2 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 1 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 3 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 2 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 4 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷